HEADER OXIDOREDUCTASE 27-JAN-23 8CCV TITLE E. COLI NFSB MUTANT T41LN71S WITH NICOTINATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DIHYDROPTERIDINE REDUCTASE,FMN-DEPENDENT NITROREDUCTASE; COMPND 5 EC: 1.-.-.-,1.5.1.34; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: DOUBLE MUTANT OF E. COLI NFSB BOUND TO NICOTINATE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 VARIANT: DH5A; SOURCE 5 GENE: NFSB, DPRA, NFNB, NFSI, NTR, B0578, JW0567; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11C KEYWDS OXYGEN INSENSITVE NAD(P)H NITROREDUCTASE, DOUBLE MUTANT, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.DAY,S.A.WHITE,E.I.HYDE,P.F.SEARLE REVDAT 1 19-APR-23 8CCV 0 JRNL AUTH M.A.DAY,A.J.CHRISTOFFERSON,J.L.R.ANDERSON,S.O.VASS,A.EVANS, JRNL AUTH 2 P.F.SEARLE,S.A.WHITE,E.I.HYDE JRNL TITL STRUCTURE AND DYNAMICS OF THREE ESCHERICHIA COLI NFSB JRNL TITL 2 NITRO-REDUCTASE MUTANTS SELECTED FOR ENHANCED ACTIVITY WITH JRNL TITL 3 THE CANCER PRODRUG CB1954. JRNL REF INT J MOL SCI V. 24 2023 JRNL REFN ESSN 1422-0067 JRNL PMID 36983061 JRNL DOI 10.3390/IJMS24065987 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0403 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 21200 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1138 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1206 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.3390 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.3670 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3352 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 167 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.96000 REMARK 3 B22 (A**2) : 0.96000 REMARK 3 B33 (A**2) : -1.93000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.293 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.221 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.191 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.120 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3506 ; 0.010 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 3302 ; 0.003 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4758 ; 1.696 ; 1.639 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7616 ; 0.638 ; 1.581 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 430 ; 6.709 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 16 ; 7.821 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 586 ;16.318 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 532 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4030 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 760 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1726 ; 2.914 ; 2.800 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1726 ; 2.910 ; 2.800 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2154 ; 4.278 ; 5.039 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2155 ; 4.277 ; 5.038 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1780 ; 3.593 ; 3.261 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1779 ; 3.581 ; 3.260 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2604 ; 5.371 ; 5.818 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4077 ; 8.339 ;31.630 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4054 ; 8.340 ;31.300 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 217 REMARK 3 ORIGIN FOR THE GROUP (A): 15.6601 7.4261 17.9637 REMARK 3 T TENSOR REMARK 3 T11: 0.1081 T22: 0.1773 REMARK 3 T33: 0.0578 T12: -0.0145 REMARK 3 T13: -0.0493 T23: 0.0411 REMARK 3 L TENSOR REMARK 3 L11: 2.9434 L22: 3.2616 REMARK 3 L33: 1.7946 L12: -0.0039 REMARK 3 L13: -0.2069 L23: 0.4216 REMARK 3 S TENSOR REMARK 3 S11: -0.0926 S12: 0.4286 S13: 0.2932 REMARK 3 S21: -0.1843 S22: 0.1818 S23: -0.0686 REMARK 3 S31: -0.1091 S32: -0.0126 S33: -0.0892 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 217 REMARK 3 ORIGIN FOR THE GROUP (A): 27.9551 -2.5912 17.7408 REMARK 3 T TENSOR REMARK 3 T11: 0.1051 T22: 0.2009 REMARK 3 T33: 0.1322 T12: 0.0117 REMARK 3 T13: -0.0211 T23: -0.0258 REMARK 3 L TENSOR REMARK 3 L11: 2.2775 L22: 3.2931 REMARK 3 L33: 1.7295 L12: 0.3148 REMARK 3 L13: -0.1970 L23: 0.0725 REMARK 3 S TENSOR REMARK 3 S11: -0.0486 S12: 0.2870 S13: -0.2040 REMARK 3 S21: -0.1815 S22: 0.1571 S23: -0.5283 REMARK 3 S31: 0.1974 S32: 0.2287 S33: -0.1085 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8CCV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1292127946. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22338 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 47.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 24.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.53000 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 4,000; 200 MM NA ACETATE, 15 REMARK 280 MM ETHYLENE GLYCOL, PH 4.6, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 131.93300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 28.43100 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 28.43100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.96650 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 28.43100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 28.43100 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 197.89950 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 28.43100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 28.43100 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 65.96650 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 28.43100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 28.43100 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 197.89950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 131.93300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 137 CD GLU A 137 OE1 0.084 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 64 45.00 -98.05 REMARK 500 LEU A 186 -50.72 -120.51 REMARK 500 ASP A 198 93.41 -68.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 73 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 8CCV A 1 217 UNP P38489 NFSB_ECOLI 1 217 DBREF 8CCV B 1 217 UNP P38489 NFSB_ECOLI 1 217 SEQADV 8CCV LEU A 41 UNP P38489 THR 41 ENGINEERED MUTATION SEQADV 8CCV SER A 71 UNP P38489 ASN 71 ENGINEERED MUTATION SEQADV 8CCV LEU B 41 UNP P38489 THR 41 ENGINEERED MUTATION SEQADV 8CCV SER B 71 UNP P38489 ASN 71 ENGINEERED MUTATION SEQRES 1 A 217 MET ASP ILE ILE SER VAL ALA LEU LYS ARG HIS SER THR SEQRES 2 A 217 LYS ALA PHE ASP ALA SER LYS LYS LEU THR PRO GLU GLN SEQRES 3 A 217 ALA GLU GLN ILE LYS THR LEU LEU GLN TYR SER PRO SER SEQRES 4 A 217 SER LEU ASN SER GLN PRO TRP HIS PHE ILE VAL ALA SER SEQRES 5 A 217 THR GLU GLU GLY LYS ALA ARG VAL ALA LYS SER ALA ALA SEQRES 6 A 217 GLY ASN TYR VAL PHE SER GLU ARG LYS MET LEU ASP ALA SEQRES 7 A 217 SER HIS VAL VAL VAL PHE CYS ALA LYS THR ALA MET ASP SEQRES 8 A 217 ASP VAL TRP LEU LYS LEU VAL VAL ASP GLN GLU ASP ALA SEQRES 9 A 217 ASP GLY ARG PHE ALA THR PRO GLU ALA LYS ALA ALA ASN SEQRES 10 A 217 ASP LYS GLY ARG LYS PHE PHE ALA ASP MET HIS ARG LYS SEQRES 11 A 217 ASP LEU HIS ASP ASP ALA GLU TRP MET ALA LYS GLN VAL SEQRES 12 A 217 TYR LEU ASN VAL GLY ASN PHE LEU LEU GLY VAL ALA ALA SEQRES 13 A 217 LEU GLY LEU ASP ALA VAL PRO ILE GLU GLY PHE ASP ALA SEQRES 14 A 217 ALA ILE LEU ASP ALA GLU PHE GLY LEU LYS GLU LYS GLY SEQRES 15 A 217 TYR THR SER LEU VAL VAL VAL PRO VAL GLY HIS HIS SER SEQRES 16 A 217 VAL GLU ASP PHE ASN ALA THR LEU PRO LYS SER ARG LEU SEQRES 17 A 217 PRO GLN ASN ILE THR LEU THR GLU VAL SEQRES 1 B 217 MET ASP ILE ILE SER VAL ALA LEU LYS ARG HIS SER THR SEQRES 2 B 217 LYS ALA PHE ASP ALA SER LYS LYS LEU THR PRO GLU GLN SEQRES 3 B 217 ALA GLU GLN ILE LYS THR LEU LEU GLN TYR SER PRO SER SEQRES 4 B 217 SER LEU ASN SER GLN PRO TRP HIS PHE ILE VAL ALA SER SEQRES 5 B 217 THR GLU GLU GLY LYS ALA ARG VAL ALA LYS SER ALA ALA SEQRES 6 B 217 GLY ASN TYR VAL PHE SER GLU ARG LYS MET LEU ASP ALA SEQRES 7 B 217 SER HIS VAL VAL VAL PHE CYS ALA LYS THR ALA MET ASP SEQRES 8 B 217 ASP VAL TRP LEU LYS LEU VAL VAL ASP GLN GLU ASP ALA SEQRES 9 B 217 ASP GLY ARG PHE ALA THR PRO GLU ALA LYS ALA ALA ASN SEQRES 10 B 217 ASP LYS GLY ARG LYS PHE PHE ALA ASP MET HIS ARG LYS SEQRES 11 B 217 ASP LEU HIS ASP ASP ALA GLU TRP MET ALA LYS GLN VAL SEQRES 12 B 217 TYR LEU ASN VAL GLY ASN PHE LEU LEU GLY VAL ALA ALA SEQRES 13 B 217 LEU GLY LEU ASP ALA VAL PRO ILE GLU GLY PHE ASP ALA SEQRES 14 B 217 ALA ILE LEU ASP ALA GLU PHE GLY LEU LYS GLU LYS GLY SEQRES 15 B 217 TYR THR SER LEU VAL VAL VAL PRO VAL GLY HIS HIS SER SEQRES 16 B 217 VAL GLU ASP PHE ASN ALA THR LEU PRO LYS SER ARG LEU SEQRES 17 B 217 PRO GLN ASN ILE THR LEU THR GLU VAL HET FMN A 301 31 HET NIO A 302 9 HET FMN B 301 31 HET NIO B 302 9 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM NIO NICOTINIC ACID HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 NIO 2(C6 H5 N O2) FORMUL 7 HOH *167(H2 O) HELIX 1 AA1 ASP A 2 ARG A 10 1 9 HELIX 2 AA2 THR A 23 SER A 37 1 15 HELIX 3 AA3 SER A 39 SER A 43 5 5 HELIX 4 AA4 THR A 53 LYS A 62 1 10 HELIX 5 AA5 SER A 63 PHE A 70 5 8 HELIX 6 AA6 SER A 71 ALA A 78 1 8 HELIX 7 AA7 ASP A 91 ASP A 105 1 15 HELIX 8 AA8 THR A 110 ASP A 131 1 22 HELIX 9 AA9 ASP A 134 LEU A 157 1 24 HELIX 10 AB1 ASP A 168 GLY A 177 1 10 HELIX 11 AB2 GLY A 177 GLY A 182 1 6 HELIX 12 AB3 ASP A 198 LEU A 203 5 6 HELIX 13 AB4 PRO A 209 THR A 213 1 5 HELIX 14 AB5 ILE B 3 ARG B 10 1 8 HELIX 15 AB6 THR B 23 TYR B 36 1 14 HELIX 16 AB7 SER B 39 SER B 43 5 5 HELIX 17 AB8 THR B 53 LYS B 62 1 10 HELIX 18 AB9 TYR B 68 ALA B 78 1 11 HELIX 19 AC1 ASP B 91 ASP B 105 1 15 HELIX 20 AC2 THR B 110 ASP B 131 1 22 HELIX 21 AC3 ASP B 134 LEU B 157 1 24 HELIX 22 AC4 ASP B 168 GLY B 177 1 10 HELIX 23 AC5 GLY B 177 GLY B 182 1 6 HELIX 24 AC6 ASP B 198 LEU B 203 5 6 HELIX 25 AC7 PRO B 209 THR B 213 1 5 SHEET 1 AA1 5 ASP A 160 ALA A 161 0 SHEET 2 AA1 5 TYR A 183 GLY A 192 -1 O GLY A 192 N ASP A 160 SHEET 3 AA1 5 HIS A 80 LYS A 87 -1 N HIS A 80 O VAL A 191 SHEET 4 AA1 5 TRP A 46 ALA A 51 -1 N ALA A 51 O VAL A 81 SHEET 5 AA1 5 LEU B 214 GLU B 216 1 O THR B 215 N VAL A 50 SHEET 1 AA2 5 LEU A 214 VAL A 217 0 SHEET 2 AA2 5 TRP B 46 ALA B 51 1 O VAL B 50 N THR A 215 SHEET 3 AA2 5 HIS B 80 LYS B 87 -1 O VAL B 81 N ALA B 51 SHEET 4 AA2 5 TYR B 183 GLY B 192 -1 O VAL B 191 N HIS B 80 SHEET 5 AA2 5 ASP B 160 ALA B 161 -1 N ASP B 160 O GLY B 192 CRYST1 56.862 56.862 263.866 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017586 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017586 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003790 0.00000